Congress Views Bills To Control Managed Care

17 March 1997

The US Congress now seems likely to set standards for healthmaintenance organizations, although employers oppose any new rules for fear this would get in the way of their controlling costs for employee benefits through managed care. Also, HMOs say they want to protect consumers but do not want any more regulations.

Congress says it is acting in response to constituents' complaints. Senator Edward Kennedy who, with Representative John Dingell, has introduced a plan to regulate managed care and protect patients' rights, says profits rather than better health has become the priority for many MCOs. Some Members of Congress also feel legislation is needed to protect doctors' abilities to exercise professional judgement.

Congress is undecided how comprehensive to make these rules or how to enforce them. It is virtually certain to pass piecemeal legislation setting standards for specific services if managed care does block comprehensive regulation, said Sen Kennedy. HMOs say complaints are only anecdotal, but they have adopted voluntary standards; Congress applauds this as self-regulation but says it will not stop it from trying to set enforceable federal standards.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight